PCSK9 as an Emerging Target for Cerebrovascular Dysfunction and Neuroinflammation in Ischemic Stroke

Carolina M. Vela, Josephin Wagner, Pal Pacher, Falk W. Lohoff

Open source

DOI
10.1021/acschemneuro.6c00171
Published
2026-07-09
Container
ACS Chemical Neuroscience
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acschemneuro.6c00171,
  title = {PCSK9 as an
Emerging Target for Cerebrovascular Dysfunction
and Neuroinflammation in Ischemic Stroke},
  author = {Carolina M. Vela and Josephin Wagner and Pal Pacher and Falk W. Lohoff},
  year = {2026},
  journal = {ACS Chemical Neuroscience},
  doi = {10.1021/acschemneuro.6c00171},
  url = {https://doi.org/10.1021/acschemneuro.6c00171}
}

RIS

TY  - JOUR
TI  - PCSK9 as an
Emerging Target for Cerebrovascular Dysfunction
and Neuroinflammation in Ischemic Stroke
AU  - Carolina M. Vela
AU  - Josephin Wagner
AU  - Pal Pacher
AU  - Falk W. Lohoff
PY  - 2026
JO  - ACS Chemical Neuroscience
DO  - 10.1021/acschemneuro.6c00171
UR  - https://doi.org/10.1021/acschemneuro.6c00171
ER  - 

APA

Vela, C. M., Wagner, J., Pacher, P., & Lohoff, F. W. (2026). PCSK9 as an Emerging Target for Cerebrovascular Dysfunction and Neuroinflammation in Ischemic Stroke. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.6c00171

Source records